Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Fixed Capital/Sales

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

BAL PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.490.390.390.390.40

What is the latest Fixed Capital/Sales ratio of BAL PHARMA ?

The latest Fixed Capital/Sales ratio of BAL PHARMA is 0.49 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.49
Mar20240.39
Mar20230.39
Mar20220.39
Mar20210.40

How is Fixed Capital/Sales of BAL PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.49
25.64
Mar2024 0.39
0.00
Mar2023 0.39
0.00
Mar2022 0.39
-2.50
Mar2021 0.4 -

Other Financial Ratios of BAL PHARMA


Compare Fixed Capital/Sales ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹106.4 Cr -1% -14.2% -19% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-1%

-14.2%

-19%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses